+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Transcatheter Embolization & Occlusion Device Market - Global Forecast 2026-2032- Product Image
Transcatheter Embolization & Occlusion Device Market - Global Forecast 2026-2032- Product Image
Sale

Transcatheter Embolization & Occlusion Device Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5639421
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Transcatheter Embolization & Occlusion Device Market is projected to reach USD 6.33 Billion in 2026. It is expected to continue growing at a CAGR of 8.34%, reaching USD 10.33 Billion by 2032.

Transcatheter embolization and occlusion devices are central to modern minimally invasive care, enabling physicians to intentionally block blood flow in targeted vessels without open surgery. The category includes embolic coils, vascular plugs, detachable balloons, particles, microspheres, liquid embolic agents, and related delivery systems used across interventional radiology, neurointervention, oncology, trauma, and peripheral vascular procedures.

Demand is supported by well-documented clinical need. The World Health Organization identifies cardiovascular disease as the leading cause of death globally, while cancer and stroke remain major sources of morbidity that frequently require image-guided vascular intervention. As hospitals prioritize shorter recovery times, lower procedural trauma, and higher precision, transcatheter embolization devices are increasingly positioned as essential tools for hemorrhage control, aneurysm management, tumor embolization, arteriovenous malformation treatment, and vessel occlusion before surgery or targeted therapy.

Transformative Shifts Reshaping Embolization and Occlusion Care

The market landscape is shifting from procedure-based device selection toward integrated, indication-specific embolization strategies. Interventional teams are increasingly matching embolic coils, plugs, liquid embolics, and microspheres to vessel anatomy, flow dynamics, imaging visibility, and retreatment risk. This is strengthening demand for deliverability, controlled deployment, radiopacity, and compatibility with microcatheters and advanced imaging platforms.

Regulatory and procurement dynamics are also changing. The U.S. FDA, European MDR framework, Japan PMDA, China NMPA, and other authorities continue to emphasize safety, biocompatibility, manufacturing controls, and post-market surveillance. At the same time, value-based healthcare is pushing suppliers to demonstrate reduced procedure time, fewer complications, predictable occlusion, and broad training support rather than relying on device features alone.

Cumulative Impact of Artificial Intelligence on Embolization

Artificial intelligence is beginning to influence the transcatheter embolization and occlusion device ecosystem through imaging, planning, workflow optimization, and evidence generation. AI-enabled segmentation, vessel mapping, and image fusion can support lesion characterization, feeding-vessel identification, and procedural planning in complex neurovascular, oncologic, and peripheral interventions. These applications are especially relevant where embolization success depends on precise navigation and complete target-vessel occlusion.

The near-term impact is expected to be decision-support rather than autonomous intervention. AI can help standardize case review, identify high-risk anatomy, reduce image interpretation variability, and support training simulations. For manufacturers, AI-assisted design analysis, manufacturing inspection, complaint trend detection, and real-world evidence analytics can improve quality systems while remaining subject to validated clinical, regulatory, cybersecurity, and data-governance requirements.

Key Regional Insights Across Asia-Pacific, North America, Europe, and Emerging Markets

Asia-Pacific is advancing rapidly as China, Japan, India, South Korea, and Australia expand interventional radiology and neurovascular capacity, supported by large patient populations, cancer care investment, and wider access to minimally invasive procedures. North America remains a high-adoption region due to established hospital networks, specialist training, favorable procedural infrastructure, and FDA-cleared device availability across peripheral, neurovascular, and oncology applications.

Europe benefits from strong clinical guideline adoption and advanced public health systems, although EU MDR compliance has increased documentation and evidence expectations for suppliers. Latin America shows growing use in Brazil and Mexico as tertiary hospitals broaden endovascular programs, while reimbursement variability continues to affect access. The Middle East is investing in high-acuity specialty hospitals, especially in GCC markets. Africa remains more uneven, with adoption concentrated in major urban referral centers where imaging, trained operators, and device availability are present.

Key Group Insights Covering ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are gaining relevance as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines increase access to tertiary interventional services, although procurement models and specialist availability vary widely. GCC countries are accelerating adoption through hospital modernization, medical tourism strategies, and investment in complex cardiovascular, oncology, and neurovascular care.

The European Union remains influential through harmonized regulatory expectations, clinical evidence requirements, and broad public-sector procurement. BRICS countries offer substantial volume potential because of large disease burdens and expanding hospital infrastructure, but pricing, local registration, and reimbursement strategy are critical. G7 markets generally lead in advanced device adoption, physician training, and clinical research output. NATO economies overlap heavily with high-income health systems, supporting demand for resilient supply chains, emergency care readiness, and standardized trauma and vascular intervention capabilities.

Key Country Insights for High-Value Embolization and Occlusion Markets

The United States leads adoption through mature interventional radiology, neurointerventional, trauma, and oncology networks, while Canada benefits from advanced care pathways but faces provincial procurement differences. Mexico and Brazil are important Latin American markets, with growth centered in private hospitals and large public referral systems. The United Kingdom, Germany, France, Italy, and Spain continue to support device utilization through established endovascular expertise, while EU MDR and national reimbursement processes shape market access. Russia maintains demand in specialized centers despite procurement and import complexity.

China is scaling embolization capacity through hospital expansion and domestic device development, while India’s demand is supported by rising cancer, trauma, and vascular disease treatment volumes alongside price sensitivity. Japan and South Korea are sophisticated markets with strong neurovascular and minimally invasive procedure adoption. Australia combines high clinical standards with concentrated specialist networks, making evidence, training, and supply reliability central to commercialization.

Actionable Recommendations for Embolization Device Industry Leaders

Industry leaders should align product development with clinical workflow realities: predictable occlusion, catheter compatibility, deliverability in tortuous anatomy, controlled deployment, and imaging visibility. Evidence strategies should move beyond technical success and include retreatment rates, complication reduction, procedure time, length of stay, and economic value for hospitals.

Commercial teams should prioritize physician education, simulation-based training, and indication-specific clinical support for neurovascular, peripheral, oncology, and trauma use cases. Manufacturers also need resilient supply chains, region-specific regulatory planning, robust post-market surveillance, and partnerships with imaging and AI vendors. Pricing strategies should reflect differentiated performance in high-income markets while offering scalable portfolios for cost-sensitive emerging healthcare systems.

Research Methodology Based on Verified Clinical and Market Evidence

This executive summary is grounded in secondary research from verified public and industry sources, including regulatory databases, clinical guidelines, peer-reviewed journals, hospital procurement indicators, patent activity, and public health datasets from organizations such as the WHO, World Bank, OECD, FDA, EMA, PMDA, NMPA, and national health agencies.

The methodology combines demand-side assessment of disease burden, procedure adoption, reimbursement structures, and hospital infrastructure with supply-side analysis of device portfolios, regulatory status, manufacturing capabilities, competitive positioning, and innovation trends. Findings are interpreted through cross-validation of clinical, commercial, and regulatory evidence to ensure that conclusions remain data-backed, current, and relevant for strategic decision-making.

Conclusion: Precision Occlusion Will Define the Next Growth Phase

The transcatheter embolization and occlusion device market is positioned for sustained strategic importance as healthcare systems expand minimally invasive treatment for vascular disease, cancer, trauma, and complex bleeding disorders. Clinical value is increasingly defined by precision, safety, workflow efficiency, and measurable outcomes rather than device availability alone.

Organizations that combine strong evidence generation, AI-enabled workflow integration, regulatory discipline, and physician-centered training will be best placed to compete. As regional access improves and therapeutic applications broaden, embolic coils, vascular plugs, liquid embolics, particles, and microspheres will remain critical technologies in image-guided intervention.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Transcatheter Embolization & Occlusion Device Market, by Product Type
7.1. Introduction
7.2. Embolization Coils
7.2.1. Detachable Coils
7.2.2. Pushable Coils
7.3. Liquid Embolic Agents
7.3.1. Ethylene Vinyl Alcohol Copolymer
7.3.2. N-Butyl Cyanoacrylate
7.4. Microspheres
7.5. Particulate Embolic Agents
7.6. Vascular Plugs
8. Transcatheter Embolization & Occlusion Device Market, by Material
8.1. Introduction
8.2. Metallic Devices
8.3. Polymer-Based Materials
8.4. Hybrid Materials
9. Transcatheter Embolization & Occlusion Device Market, by Technology
9.1. Introduction
9.2. Flow Directed Embolization
9.3. Mechanical Occlusion
9.4. Microcatheter Delivery Systems
10. Transcatheter Embolization & Occlusion Device Market, by Indication Type
10.1. Introduction
10.2. Benign Conditions
10.3. Malignant Conditions
10.4. Emergency Conditions
11. Transcatheter Embolization & Occlusion Device Market, by Application
11.1. Introduction
11.2. Hemorrhage Control
11.3. Hepatic Embolization
11.4. Neurovascular Embolization
11.5. Peripheral Vascular Embolization
11.6. Uterine Fibroid Embolization
12. Transcatheter Embolization & Occlusion Device Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Hospitals
12.4. Specialty Clinics
13. Transcatheter Embolization & Occlusion Device Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Transcatheter Embolization & Occlusion Device Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Transcatheter Embolization & Occlusion Device Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Acandis GmbH
17.3. AngioDynamics, Inc.
17.4. AtriCure, Inc.
17.5. B. Braun Melsungen AG
17.6. Balt International
17.7. Boston Scientific Corporation
17.8. Cardiva Medical, Inc.
17.9. Cook Medical LLC
17.10. Edwards Lifesciences Corporation
17.11. Guerbet S.A.
17.12. Kaneka Corporation
17.13. Medtronic plc
17.14. Merit Medical Systems, Inc.
17.15. MicroVention, Inc.
17.16. Penumbra, Inc.
17.17. Sirtex Medical Limited
17.18. Stryker Corporation
17.19. Teleflex Incorporated
17.20. Terumo Corporation
List of Figures
FIGURE 1. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2025 VS 2032 (%)
FIGURE 9. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL EMBOLIZATION COILS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL EMBOLIZATION COILS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL EMBOLIZATION COILS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL DETACHABLE COILS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL DETACHABLE COILS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL DETACHABLE COILS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL PUSHABLE COILS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL PUSHABLE COILS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL PUSHABLE COILS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL LIQUID EMBOLIC AGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL LIQUID EMBOLIC AGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL LIQUID EMBOLIC AGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL ETHYLENE VINYL ALCOHOL COPOLYMER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL ETHYLENE VINYL ALCOHOL COPOLYMER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL ETHYLENE VINYL ALCOHOL COPOLYMER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL N-BUTYL CYANOACRYLATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL N-BUTYL CYANOACRYLATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL N-BUTYL CYANOACRYLATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL MICROSPHERES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL MICROSPHERES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL MICROSPHERES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL PARTICULATE EMBOLIC AGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL PARTICULATE EMBOLIC AGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL PARTICULATE EMBOLIC AGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL VASCULAR PLUGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL VASCULAR PLUGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL VASCULAR PLUGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL METALLIC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL METALLIC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL METALLIC DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL POLYMER-BASED MATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL POLYMER-BASED MATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL POLYMER-BASED MATERIALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL HYBRID MATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL HYBRID MATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL HYBRID MATERIALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL FLOW DIRECTED EMBOLIZATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL FLOW DIRECTED EMBOLIZATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL FLOW DIRECTED EMBOLIZATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL MECHANICAL OCCLUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL MECHANICAL OCCLUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL MECHANICAL OCCLUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL MICROCATHETER DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL MICROCATHETER DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL MICROCATHETER DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL BENIGN CONDITIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL BENIGN CONDITIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL BENIGN CONDITIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL MALIGNANT CONDITIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL MALIGNANT CONDITIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL MALIGNANT CONDITIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL EMERGENCY CONDITIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL EMERGENCY CONDITIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL EMERGENCY CONDITIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL HEMORRHAGE CONTROL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL HEMORRHAGE CONTROL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL HEMORRHAGE CONTROL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL HEPATIC EMBOLIZATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL HEPATIC EMBOLIZATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL HEPATIC EMBOLIZATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL NEUROVASCULAR EMBOLIZATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL NEUROVASCULAR EMBOLIZATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL NEUROVASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL PERIPHERAL VASCULAR EMBOLIZATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL PERIPHERAL VASCULAR EMBOLIZATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL PERIPHERAL VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL UTERINE FIBROID EMBOLIZATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL UTERINE FIBROID EMBOLIZATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL UTERINE FIBROID EMBOLIZATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 97. NORTH AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. NORTH AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 99. NORTH AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 100. NORTH AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 101. NORTH AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 102. NORTH AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 103. NORTH AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 104. NORTH AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 105. NORTH AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 106. LATIN AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. LATIN AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 108. LATIN AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 109. LATIN AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 110. LATIN AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 111. LATIN AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 112. LATIN AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 113. LATIN AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 114. LATIN AMERICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 115. EUROPE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. EUROPE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 117. EUROPE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 118. EUROPE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 119. EUROPE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 120. EUROPE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 121. EUROPE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 122. EUROPE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 123. EUROPE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 124. MIDDLE EAST TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. MIDDLE EAST TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 126. MIDDLE EAST TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 127. MIDDLE EAST TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 128. MIDDLE EAST TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 129. MIDDLE EAST TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 130. MIDDLE EAST TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 131. MIDDLE EAST TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 132. MIDDLE EAST TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 133. AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 135. AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 136. AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 137. AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 138. AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 139. AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 140. AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 141. AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 143. ASEAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 144. ASEAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 145. ASEAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 146. ASEAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 147. ASEAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 148. ASEAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 149. ASEAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 150. ASEAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 151. ASEAN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 152. GCC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 153. GCC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 154. GCC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 155. GCC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 156. GCC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 157. GCC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 158. GCC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 159. GCC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 160. GCC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 170. BRICS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 171. BRICS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 172. BRICS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 173. BRICS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 174. BRICS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 175. BRICS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 176. BRICS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 177. BRICS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 178. BRICS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 179. G7 TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 180. G7 TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 181. G7 TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 182. G7 TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 183. G7 TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 184. G7 TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 185. G7 TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 186. G7 TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 187. G7 TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 188. NATO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 189. NATO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 190. NATO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 191. NATO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 192. NATO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 193. NATO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 194. NATO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 195. NATO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 196. NATO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 197. GLOBAL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 198. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 199. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 200. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 201. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 202. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 203. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 204. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 205. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 206. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 207. CANADA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 208. CANADA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 209. CANADA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 210. CANADA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 211. CANADA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 212. CANADA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 213. CANADA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 214. CANADA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 215. CANADA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 216. MEXICO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 217. MEXICO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 218. MEXICO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 219. MEXICO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 220. MEXICO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 221. MEXICO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 222. MEXICO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 223. MEXICO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 224. MEXICO TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 225. BRAZIL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 226. BRAZIL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 227. BRAZIL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 228. BRAZIL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 229. BRAZIL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 230. BRAZIL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 231. BRAZIL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 232. BRAZIL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 233. BRAZIL TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 234. UNITED KINGDOM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 235. UNITED KINGDOM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 236. UNITED KINGDOM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 237. UNITED KINGDOM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 238. UNITED KINGDOM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 239. UNITED KINGDOM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 240. UNITED KINGDOM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 241. UNITED KINGDOM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 242. UNITED KINGDOM TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 243. GERMANY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 244. GERMANY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 245. GERMANY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 246. GERMANY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 247. GERMANY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 248. GERMANY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 249. GERMANY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 250. GERMANY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 251. GERMANY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 252. FRANCE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 253. FRANCE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 254. FRANCE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 255. FRANCE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 256. FRANCE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 257. FRANCE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 258. FRANCE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 259. FRANCE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 260. FRANCE TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 261. RUSSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 262. RUSSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 263. RUSSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 264. RUSSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 265. RUSSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 266. RUSSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 267. RUSSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 268. RUSSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 269. RUSSIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 270. ITALY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 271. ITALY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 272. ITALY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 273. ITALY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 274. ITALY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 275. ITALY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 276. ITALY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 277. ITALY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 278. ITALY TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 279. SPAIN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 280. SPAIN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 281. SPAIN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 282. SPAIN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 283. SPAIN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 284. SPAIN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 285. SPAIN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 286. SPAIN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 287. SPAIN TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 288. CHINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 289. CHINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 290. CHINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY EMBOLIZATION COILS, 2017-2032 (USD MILLION)
TABLE 291. CHINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY LIQUID EMBOLIC AGENTS, 2017-2032 (USD MILLION)
TABLE 292. CHINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 293. CHINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 294. CHINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY INDICATION TYPE, 2017-2032 (USD MILLION)
TABLE 295. CHINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 296. CHINA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 297. INDIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 298. INDIA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVIC

Companies Mentioned

  • Abbott Laboratories
  • Acandis GmbH
  • AngioDynamics, Inc.
  • AtriCure, Inc.
  • B. Braun Melsungen AG
  • Balt International
  • Boston Scientific Corporation
  • Cardiva Medical, Inc.
  • Cook Medical LLC
  • Edwards Lifesciences Corporation
  • Guerbet S.A.
  • Kaneka Corporation
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroVention, Inc.
  • Penumbra, Inc.
  • Sirtex Medical Limited
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation

Table Information

Report AttributeDetails
No. of Pages184
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 6.33 Billion
Forecasted Market Value ( USD ) by 2032 $ 10.33 Billion
Compound Annual Growth Rate8.3%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Transcatheter Embolization and Occlusion Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Transcatheter Embolization and Occlusion Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Transcatheter Embolization and Occlusion Devices - Global Strategic Business Report - Product Image

Transcatheter Embolization and Occlusion Devices - Global Strategic Business Report

  • Report
  • 230 Pages
  • Global
From
Transcatheter Embolization and Occlusion Device Market: Growth, Trends, and Competitive Landscape - Product Image

Transcatheter Embolization and Occlusion Device Market: Growth, Trends, and Competitive Landscape

  • Report
  • 117 Pages
  • Global
From
Transcatheter Embolization and Occlusion Devices Market Report 2026 - Product Image

Transcatheter Embolization and Occlusion Devices Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Coil Transcatheter Embolization and Occlusion Devices Market Report 2026 - Product Image

Coil Transcatheter Embolization and Occlusion Devices Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.